Daniel Grosslight, an analyst from Citi, maintained the Hold rating on Cardinal Health (CAH – Research Report). The associated price ...
PharmAla will seek to finalize the license and data sharing agreement prior to the conclusion of the 2024 calendar year. The identity of the trial Principal Investigators and institution is currently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback